203 related articles for article (PubMed ID: 9845405)
1. Effects of tablet and effervescent formulations of ranitidine 75 mg and cimetidine 200 mg on gastric acidity and oesophageal acid exposure in healthy humans.
Bruley des Varannes S; Duquesnoy C; Mamet JP; Slama A; Galmiche JP; Scarpignato C
Aliment Pharmacol Ther; 1998 Nov; 12(11):1155-61. PubMed ID: 9845405
[TBL] [Abstract][Full Text] [Related]
2. Effect of an evening dose of regular and effervescent formulations of ranitidine or cimetidine on intragastric pH in healthy volunteers.
Smout AJ; Jonkman JH; Peeters PA; De Bruin H
Aliment Pharmacol Ther; 1995 Feb; 9(1):51-6. PubMed ID: 7766744
[TBL] [Abstract][Full Text] [Related]
3. Low-dose famotidine and effervescent cimetidine in healthy subjects: a placebo-controlled overnight pH study.
Reilly TG; Grimley CE; Usselmann B; Cottrell J; Mann SG; Raskin S; Nwokolo CU
Aliment Pharmacol Ther; 1998 May; 12(5):469-74. PubMed ID: 9663728
[TBL] [Abstract][Full Text] [Related]
4. Decrease of intragastric acidity in healthy subjects dosed with ranitidine 75 mg, cimetidine 200 mg, or placebo.
Hamilton MI; Sercombe J; Pounder RE
Dig Dis Sci; 2002 Jan; 47(1):54-7. PubMed ID: 11837732
[TBL] [Abstract][Full Text] [Related]
5. In single doses ranitidine effervescent is more effective than lansoprazole in decreasing gastric acidity.
Arnestad JS; Kleveland PM; Waldum HL
Aliment Pharmacol Ther; 1997 Apr; 11(2):355-8. PubMed ID: 9146775
[TBL] [Abstract][Full Text] [Related]
6. Effervescent and standard formulations of ranitidine--a comparison of their pharmacokinetics and pharmacology.
Watson RG; Johnston BT; Tham TC; Kersey K
Aliment Pharmacol Ther; 1996 Dec; 10(6):913-8. PubMed ID: 8971288
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of intragastric acidity in healthy subjects dosed with ranitidine 75 mg: a comparative study with cimetidine and placebo.
Grimley CE; Constantinides S; Snell CC; Mills JG; Nwokolo CU
Aliment Pharmacol Ther; 1997 Oct; 11(5):875-9. PubMed ID: 9354195
[TBL] [Abstract][Full Text] [Related]
8. Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man?
Bauerfeind P; Cilluffo T; Fimmel CJ; Emde C; von Ritter C; Kohler W; Gugler R; Gasser T; Blum AL
Gut; 1987 May; 28(5):549-56. PubMed ID: 3596336
[TBL] [Abstract][Full Text] [Related]
9. Molecular pharmacological approaches to effects of capsaicinoids and of classical antisecretory drugs on gastric basal acid secretion and on indomethacin-induced gastric mucosal damage in human healthy subjects (mini review).
Szabó IL; Czimmer J; Szolcsányi J; Mózsik G
Curr Pharm Des; 2013; 19(1):84-9. PubMed ID: 22946903
[TBL] [Abstract][Full Text] [Related]
10. Comparison of gastric mucosal surface pH response times after intravenous administration of histamine2-receptor antagonists.
Katsu K; Yabe S
Clin Ther; 1995; 17(3):433-10. PubMed ID: 7585847
[TBL] [Abstract][Full Text] [Related]
11. Synergy between low-dose ranitidine and antacid in decreasing gastric and oesophageal acidity and relieving meal-induced heartburn.
Robinson M; Rodriguez-Stanley S; Ciociola AA; Filinto J; Zubaidi S; Miner PB; Gardner JD
Aliment Pharmacol Ther; 2001 Sep; 15(9):1365-74. PubMed ID: 11552907
[TBL] [Abstract][Full Text] [Related]
12. Impact of food intake on the antisecretory effect of low-dose ranitidine and famotidine.
Netzer P; Eschenmoser K; Halter F; Inauen W
Aliment Pharmacol Ther; 1999 Mar; 13(3):407-12. PubMed ID: 10102975
[TBL] [Abstract][Full Text] [Related]
13. Intravenous cimetidine or two regimens of ranitidine to reduce fasting gastric acidity.
Peterson WL; Richardson CT
Ann Intern Med; 1986 Apr; 104(4):505-7. PubMed ID: 3954278
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of ranitidine effervescent tablets and magnesium hydroxide-aluminium oxide on intragastric acidity. A single-centre, randomised, open cross-over study.
Propst A; Propst T; Judmaier G
Arzneimittelforschung; 1996 Jun; 46(6):621-4. PubMed ID: 8767354
[TBL] [Abstract][Full Text] [Related]
15. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J
Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
[TBL] [Abstract][Full Text] [Related]
16. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
[TBL] [Abstract][Full Text] [Related]
17. Effects of a single low dose of ranitidine and effervescent antacids on intragastric acidity in healthy volunteers.
Améndola R; Santos MC; Massa JM; Vazquez H; Smecuol E
Acta Gastroenterol Latinoam; 2007 Dec; 37(4):231-7. PubMed ID: 18254261
[TBL] [Abstract][Full Text] [Related]
18. Effects of ranitidine and of cimetidine on pentagastrin-stimulated gastric acid secretion.
Holloway RH; Kuljian B; Eshelman F; McCallum RW
Clin Pharmacol Ther; 1984 Feb; 35(2):203-7. PubMed ID: 6319068
[TBL] [Abstract][Full Text] [Related]
19. Long-term ambulatory gastric pH monitoring: validation of a new method and effect of H2-antagonists.
Fimmel CJ; Etienne A; Cilluffo T; von Ritter C; Gasser T; Rey JP; Caradonna-Moscatelli P; Sabbatini F; Pace F; Bühler HW
Gastroenterology; 1985 Jun; 88(6):1842-51. PubMed ID: 3996841
[TBL] [Abstract][Full Text] [Related]
20. Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers.
Hedenström H; Alm C; Kraft M; Grahnén A
Aliment Pharmacol Ther; 1997 Dec; 11(6):1137-41. PubMed ID: 9663842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
